Berkeley Capital Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$233K Sell
1,927
-350
-15% -$42.4K 0.06% 156
2025
Q1
$254K Sell
2,277
-131
-5% -$14.6K 0.07% 149
2024
Q4
$234K Sell
2,408
-3,608
-60% -$351K 0.07% 156
2024
Q3
$692K Sell
6,016
-12,188
-67% -$1.4M 0.2% 99
2024
Q2
$1.94M Buy
18,204
+52
+0.3% +$5.54K 0.58% 29
2024
Q1
$1.76M Buy
18,152
+11,893
+190% +$1.15M 0.54% 34
2023
Q4
$632K Sell
6,259
-178
-3% -$18K 0.21% 93
2023
Q3
$656K Sell
6,437
-259
-4% -$26.4K 0.24% 81
2023
Q2
$676K Sell
6,696
-9,857
-60% -$995K 0.24% 81
2023
Q1
$1.52M Buy
16,553
+231
+1% +$21.3K 0.56% 33
2022
Q4
$1.48M Buy
16,322
+700
+4% +$63.5K 0.57% 33
2022
Q3
$1.19M Buy
15,622
+1,535
+11% +$117K 0.51% 35
2022
Q2
$1.19M Buy
14,087
+1,530
+12% +$129K 0.49% 34
2022
Q1
$1.1M Buy
12,557
+8,713
+227% +$765K 0.44% 36
2021
Q4
$336K Buy
3,844
+981
+34% +$85.7K 0.14% 102
2021
Q3
$234K Buy
2,863
+65
+2% +$5.31K 0.11% 124
2021
Q2
$255K Sell
2,798
-168
-6% -$15.3K 0.11% 118
2021
Q1
$254K Buy
2,966
+143
+5% +$12.2K 0.12% 106
2020
Q4
$267K Buy
2,823
+25
+0.9% +$2.37K 0.14% 98
2020
Q3
$243K Sell
2,798
-126
-4% -$10.9K 0.15% 91
2020
Q2
$255K Sell
2,924
-103
-3% -$8.98K 0.16% 90
2020
Q1
$250K Sell
3,027
-250
-8% -$20.6K 0.17% 98
2019
Q4
$310K Sell
3,277
-27
-0.8% -$2.55K 0.16% 106
2019
Q3
$287K Sell
3,304
-124
-4% -$10.8K 0.15% 113
2019
Q2
$313K Sell
3,428
-426
-11% -$38.9K 0.15% 111
2019
Q1
$332K Buy
3,854
+118
+3% +$10.2K 0.16% 104
2018
Q4
$287K Buy
3,736
+67
+2% +$5.15K 0.16% 106
2018
Q3
$283K Buy
+3,669
New +$283K 0.16% 103
2017
Q4
Sell
-2,974
Closed -$229K 122
2017
Q3
$229K Sell
2,974
-4,353
-59% -$335K 0.15% 112
2017
Q2
$548K Buy
+7,327
New +$548K 0.37% 68